Screener
Cytokinetics CYTK Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Net product revenue | $25,334 | — | $30,123 | — |
| Collaboration revenues | 3,290 | 2,416 | 5,927 | 3,995 |
| License and milestone revenues | — | 64,353 | 11,929 | 64,353 |
| Total revenues | 28,624 | 66,769 | 47,979 | 68,348 |
| Operating expenses: | ||||
| Research and development | 97,807 | 110,138 | 193,332 | 208,400 |
| Selling, general and administrative | 104,397 | 65,721 | 209,293 | 123,090 |
| Cost of goods sold | 2,731 | — | 2,891 | — |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Cytokinetics's total revenue?
- Cytokinetics (CYTK) reported total revenue of $28.62M in Q2 2026.
- How has Cytokinetics's total revenue changed year-over-year?
- Cytokinetics's total revenue decreased by 57.1% year-over-year, from $66.77M to $28.62M.
- What is the long-term trend for Cytokinetics's total revenue?
- Over 4 years (2021 to 2025), Cytokinetics's total revenue has grown at a 5.7% compound annual growth rate (CAGR), from $70.43M to $88.04M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Cytokinetics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude